Neurocrine Biosciences Inc (NBIX): Shares Outstanding
100.10M
As of 2025-12-31
101.60M
As of 2026-06-30
+1.2%
3-year compound annual growth
+1.4%
5-year compound annual growth
+1.5%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 100.10M | +0.7% | 2026-02-11, Balance as of period end |
| 2024-12-31 | 99.40M | +0.7% | 2026-02-11, Balance as of period end |
| 2023-12-31 | 98.70M | +2.3% | 2025-02-10, Balance as of period end |
| 2022-12-31 | 96.50M | +1.7% | 2024-02-09, Balance as of period end |
| 2021-12-31 | 94.90M | +1.5% | 2023-02-09, Balance as of period end |
| 2020-12-31 | 93.50M | +1.3% | 2022-02-11, Balance as of period end |
| 2019-12-31 | 92.30M | +1.7% | 2021-02-05, Balance as of period end |
| 2018-12-31 | 90.80M | +2.3% | 2020-02-07, Balance as of period end |
| 2017-12-31 | 88.79M | +2.2% | 2019-02-08, Balance as of period end |
| 2016-12-31 | 86.88M | +0.7% | 2018-02-13, Balance as of period end |
| 2015-12-31 | 86.26M | +12.8% | 2017-02-14, Balance as of period end |
| 2014-12-31 | 76.47M | +13.5% | 2016-02-11, Balance as of period end |
| 2013-12-31 | 67.35M | +1.4% | 2015-02-09, Balance as of period end |
| 2012-12-31 | 66.45M | +20.2% | 2014-02-11, Balance as of period end |
| 2011-12-31 | 55.26M | +0.7% | 2013-02-08, Balance as of period end |
| 2010-12-31 | 54.88M | n/a | 2012-02-09, Balance as of period end |